Certara (NASDAQ:CERT) Now Covered by Analysts at Craig Hallum

Research analysts at Craig Hallum initiated coverage on shares of Certara (NASDAQ:CERT) in a note issued to investors on Monday, MarketBeat reports. The brokerage set a “buy” rating on the stock.

Other equities research analysts have also issued research reports about the company. UBS Group reduced their price target on Certara from $17.50 to $15.00 and set a “buy” rating on the stock in a research report on Thursday, August 7th. Zacks Research upgraded Certara from a “strong sell” rating to a “hold” rating in a research report on Friday, September 5th. Morgan Stanley initiated coverage on Certara in a research report on Thursday, July 3rd. They set an “equal weight” rating and a $16.00 target price on the stock. Finally, KeyCorp cut their target price on Certara from $18.00 to $15.00 and set an “overweight” rating on the stock in a research report on Monday, July 14th. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $15.25.

Certara Trading Up 0.3%

NASDAQ CERT opened at $12.22 on Monday. The business’s 50-day moving average price is $10.94 and its two-hundred day moving average price is $11.29. Certara has a 12 month low of $8.64 and a 12 month high of $15.69. The firm has a market capitalization of $1.96 billion, a PE ratio of 244.45 and a beta of 1.43. The company has a current ratio of 2.16, a quick ratio of 2.16 and a debt-to-equity ratio of 0.27.

Certara (NASDAQ:CERT) last released its quarterly earnings results on Wednesday, August 6th. The company reported $0.07 EPS for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.03). Certara had a net margin of 1.97% and a return on equity of 5.11%. The company had revenue of $104.57 million during the quarter, compared to the consensus estimate of $104.14 million. During the same quarter last year, the firm posted $0.07 EPS. The company’s quarterly revenue was up 12.1% on a year-over-year basis. On average, analysts expect that Certara will post 0.28 EPS for the current year.

Insider Transactions at Certara

In other Certara news, insider Leif E. Pedersen sold 51,224 shares of the stock in a transaction that occurred on Tuesday, September 9th. The stock was sold at an average price of $10.92, for a total value of $559,366.08. Following the transaction, the insider owned 73,979 shares in the company, valued at approximately $807,850.68. This represents a 40.91% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 2.33% of the company’s stock.

Institutional Trading of Certara

A number of institutional investors and hedge funds have recently modified their holdings of the business. Corient Private Wealth LLC increased its position in shares of Certara by 11.1% during the second quarter. Corient Private Wealth LLC now owns 12,299 shares of the company’s stock valued at $144,000 after acquiring an additional 1,232 shares during the last quarter. Texas Permanent School Fund Corp increased its position in shares of Certara by 44.5% during the second quarter. Texas Permanent School Fund Corp now owns 86,019 shares of the company’s stock valued at $1,006,000 after acquiring an additional 26,480 shares during the last quarter. Osaic Holdings Inc. increased its position in shares of Certara by 50.7% during the second quarter. Osaic Holdings Inc. now owns 3,491 shares of the company’s stock valued at $41,000 after acquiring an additional 1,175 shares during the last quarter. Public Sector Pension Investment Board increased its position in shares of Certara by 8.3% during the second quarter. Public Sector Pension Investment Board now owns 376,100 shares of the company’s stock valued at $4,400,000 after acquiring an additional 28,924 shares during the last quarter. Finally, Tower Research Capital LLC TRC increased its position in shares of Certara by 499.5% during the second quarter. Tower Research Capital LLC TRC now owns 5,917 shares of the company’s stock valued at $69,000 after acquiring an additional 4,930 shares during the last quarter. 73.96% of the stock is owned by hedge funds and other institutional investors.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.